HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days--Implications for HIV Remission.
about
How to Define the Latent Reservoir: Tools of the TradePerspectives for immunotherapy: which applications might achieve an HIV functional cure?Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIVResidual Viremia in Treated HIV+ IndividualsModeling of Experimental Data Supports HIV Reactivation from Latency after Treatment Interruption on Average Once Every 5-8 Days.Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy.Insufficient Evidence for Rare Activation of Latent HIV in the Absence of Reservoir-Reducing Interventions.Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection.Development of 5' LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individualsHIV-1 cellular and tissue replication patterns in infected humanized mice.HIV-1 Reservoirs During Suppressive Therapy.Curing HIV: Moving Forward Faster.Kill: boosting HIV-specific immune responses.Epigenetics and Genetics of Viral Latency.Autologous Stem Cell Transplantation Disrupts Adaptive Immune Responses during Rebound Simian/Human Immunodeficiency Virus Viremia.Interplay between Autophagy, Exosomes and HIV-1 Associated Neurological Disorders: New Insights for Diagnosis and Therapeutic Applications.Treatment interruption after 2-year antiretroviral treatment initiated during acute/early HIV in infancy.Anti-proliferative therapy for HIV cure: a compound interest approach.Relationship between Measures of HIV Reactivation and Decline of the Latent Reservoir under Latency-Reversing Agents.Pharmacodynamics of anti-HIV gene therapy using viral vectors and targeted endonucleases.Modeling of Antilatency Treatment in HIV: What Is the Optimal Duration of Antiretroviral Therapy-Free HIV Remission?Control of HIV infection by IFN-α: implications for latency and a cure.Correction: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV Remission.Mechanisms of CNS Viral Seeding by HIV+ CD14+ CD16+ Monocytes: Establishment and Reseeding of Viral Reservoirs Contributing to HIV-Associated Neurocognitive Disorders.Triterpenoids from Ocimum labiatum Activates Latent HIV-1 Expression In Vitro: Potential for Use in Adjuvant Therapy.Nonhuman Primate Models for Studies of AIDS Virus Persistence During Suppressive Combination Antiretroviral Therapy.Modeling Kick-Kill Strategies toward HIV Cure.What do we measure when we measure cell-associated HIV RNA.Mathematical Models of HIV Latency.Estimating Initial Viral Levels during Simian Immunodeficiency Virus/Human Immunodeficiency Virus Reactivation from Latency.Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents.The role of catecholamines in HIV neuropathogenesis.Secondary lymphoid organ fibroblastic reticular cells mediate trans-infection of HIV-1 via CD44-hyaluronan interactions.FDG-PET/CT activity leads to the diagnosis of unsuspected TB: a retrospective study.Viral diversity is an obligate consideration in CRISPR/Cas9 designs for targeting the HIV reservoir.Modeling HIV persistence and cure studiesPhylogenetic approach to recover integration dates of latent HIV sequences within-hostInsight into treatment of HIV infection from viral dynamics modelsTargeting Immune Checkpoint Molecules to Eliminate Latent HIV
P2860
Q26766705-DE91634B-6A1D-49A1-BD44-9CC783A77B5CQ28078726-620E6883-20E5-4A1C-84A9-1439B20DCC48Q28551642-C5342C1B-8287-4624-8530-88D58E72E28FQ28552126-6108BC1B-ABC3-44B6-98C6-7BCF77385C24Q31123548-1F7F6FC8-DC0C-49A3-97CE-E01CD4466E19Q33693987-CA81830A-A063-47B0-A11A-D8863725CB71Q36113077-DCC21829-0470-45C7-8F4C-73D210462557Q36274030-CFE2AF2A-611B-475B-9DEF-83F03750DEB1Q36596027-DCA344D7-4036-4084-887A-05EFEF89C9EAQ36709101-C4F038AE-67BB-4A8F-A2C9-498D9B4E92ABQ37656766-BD30AAC7-9B2D-4138-8CBA-6C78974B5BFCQ38581140-95402639-60F4-4B8C-B7FB-D57C7587EC1AQ38800533-EF1043DA-9C3C-4F4F-ADC7-D99E9F227625Q38833222-FDF013AA-3D8F-4C08-A2C0-F8E42A18F006Q38839394-B23D80A0-CA1E-41BD-9C74-56D861175E9BQ39419450-1D4A2E52-6542-41E5-A04E-6E60A3B4F59DQ39768190-C14F7647-84C6-4155-AA07-A8DF867E592BQ40150493-77E8D601-43AA-49AA-9712-AC903E5D5182Q40331404-2000F6E8-DFBE-4C08-A63A-6137BFD5CBAAQ40709550-CD25176D-84D3-49E2-B59A-533D97DC25C5Q41918728-64BEDB7F-9E2C-4A03-B687-BE689E552C55Q41922021-736FE379-DBB7-4C11-B86B-069079FDAA63Q42332531-DD758EC2-9DBA-4531-BE05-DF02780AC7A0Q42638904-1A30CDE5-151C-4BBC-AFA7-FFF7E100009CQ43924337-994761DC-04A9-4A1A-8D8B-DC23EE7E1DF9Q45326424-9000D321-0BD5-41CA-AC1E-91E5D17FCAC7Q47098032-3E165D1A-6546-463D-892B-B2CF3065A053Q47548192-B48F0AF9-F224-4254-B36A-A7BC291FF613Q47574091-F968E7B4-ED37-4F20-8D40-6EC9FB592D51Q47585986-DE75833A-86FA-4948-A9C3-C5ED5A997013Q49925023-E832D4CA-E720-479E-AAA2-E7CF307EA107Q53828206-CF10E7D2-7BFA-48A6-89A9-C6165A49DC60Q55261162-DC76CD24-9003-4196-B162-0BDFE8B976CBQ55644781-DD090D5A-A4CC-4E35-920B-F028688321EFQ55654521-C1093DCE-E33E-4F18-9648-45CBAA4210EFQ57163191-796935C6-5156-4852-83ED-FFEBBB3AF890Q58762598-B17140A5-49A1-4C23-AB23-E571FACC7876Q58788145-2E9981CF-5B66-4F50-800F-A046AD7822E4Q59127701-627A49DF-266B-4323-8753-7781D099C967
P2860
HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days--Implications for HIV Remission.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
HIV Reactivation from Latency ...... mplications for HIV Remission.
@ast
HIV Reactivation from Latency ...... mplications for HIV Remission.
@en
type
label
HIV Reactivation from Latency ...... mplications for HIV Remission.
@ast
HIV Reactivation from Latency ...... mplications for HIV Remission.
@en
prefLabel
HIV Reactivation from Latency ...... mplications for HIV Remission.
@ast
HIV Reactivation from Latency ...... mplications for HIV Remission.
@en
P2093
P2860
P50
P1433
P1476
HIV Reactivation from Latency ...... mplications for HIV Remission.
@en
P2093
Andrew J Grimm
David A Cooper
Mykola Pinkevych
P2860
P304
P356
10.1371/JOURNAL.PPAT.1005000
P50
P577
2015-07-02T00:00:00Z